[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"canities\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:canities":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,43,69],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100592841","6-month-trial-of-chinese-herbal-treatments-for-hair-loss-and-gray-hair-100592841",false,"NCT06998680","6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair","A 6-Month Randomized Double-Blind Placebo-Controlled Trial Assessing the Efficacy of Oral and Topical Traditional Chinese Medicine Products on Alopecia and Canities","Inclusion Criteria:\n\n1. Participants must sign the informed consent form prior to enrollment and fully understand the study's purpose, procedures, and potential adverse events.\n2. Adults aged 18 to 60 years, both male and female; each group must include no less than 50% female participants.\n3. Hair length must be greater than 5 cm.\n4. Women must meet the Savin scale classification between grades 1-3 to II.\n5. Men must meet the Norwood-Hamilton classification between stages II and VI.\n6. At least 10 participants in each group must have gray hair, with a minimum of 5 gray hairs within a 1 cm × 4 cm area of the scalp.\n7. Participants must not have undergone any special hair treatments-such as dyeing, perming, or styling-within the past two months.\n\nExclusion Criteria:\n\n1. Pregnant or breastfeeding women, or individuals planning to conceive in the near future.\n2. Individuals with medical conditions causing hair loss, such as refractory alopecia areata, inflammatory scarring alopecia, or psoriatic alopecia; or those diagnosed with other scalp or hair disorders.\n3. Individuals with diagnosed psychiatric or psychological disorders, or those with long-term sleep disturbances or emotional regulation issues.\n4. Use of anti-hair loss cosmetics or other hair growth-promoting products within the past 3 months.\n5. Use of any systemic or topical medications known to affect hair growth within the past 6 months.\n6. History of hair transplantation.\n7. Curly hair.\n8. Individuals with highly sensitive constitutions.\n9. Individuals diagnosed with severe anemia or abnormal liver\u002Fkidney function during physical examination.\n10. Participation in any other clinical trials involving the test area within the past 2 months.\n11. Any other conditions deemed unsuitable for participation by the clinical investigators.",true,"ALL","18 Years","60 Years",{"count":21,"type":22},152,"ESTIMATED","INTERVENTIONAL",[25],"NA","This will be a 6-month randomized, double-blind, placebo-controlled trial. A total of 152 participants with hair loss, including some with gray hair, will be enrolled and randomly assigned to four groups. Each group will receive a combination of oral capsules and hair tonic, to be used as directed for 24 weeks. Participants will attend three in-person visits, during which assessments-including hair-related tests and photographs-will be conducted to evaluate hair count and density. Additionally, 10 participants with gray hair from each group will undergo extra assessments focused on changes in hair color. All relevant clinical data will be systematically collected and recorded for statistical analysis.",[28,29],"Alopecia","Canities","RECRUITING","2025-09-15",{"date":33,"type":34},"2025-09-19","ACTUAL",{"date":36,"type":34},"2025-07-30",{"date":38,"type":22},"2026-10-30",{"name":40,"class":41},"Vita Green Pharmaceutical (H.K.) Ltd.","INDUSTRY",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":23,"phases":53,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":4},"100605733","phase-1-clinical-study-of-mtor-inhibitor-as-a-treatment-for-grey-hair-canities-100605733","NCT07166354","Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)","Inclusion Criteria:\n\n* Age 30 to 65\n* Diagnosed with Grey Hair (Canities)\n* Willing and able to apply the treatment as directed, comply with study\n* Otherwise healthy\n* Able to give informed consent\n\nExclusion Criteria:\n\n* A medical history that may interfere with study objectives\n* Women who are pregnant, lactating, or planning to become pregnant during the study period\n* Subjects who have experienced a clinically important medical event within 90 days of the visit (e.g., stroke, myocardial infarction, etc)\n* Subjects who have known allergies to any excipient in CS-001\n* Subjects who are currently participating in another clinical study or have completed another clinical study with an investigational drug or device in the treatment area within 30 days prior to study treatment initiation\n* Subjects who have used any topical prescription medications in the treatment area within 30 days prior to study treatment initiation\n* Subjects who have had a dermatological procedure such as surgery in the treatment area within 30 days prior to study treatment initiation\n* Subject is unable to provide consent or make the allotted clinical visits","30 Years","65 Years",{"count":52,"type":22},100,[54,55],"PHASE1","PHASE2","Clinical Study to Assess the Safety and Efficacy of CS-002 (mTOR inhibitor) as a treatment for Canities (Grey Hair)",[29,58],"Grey Hair","NOT_YET_RECRUITING","2025-09-03",{"date":62,"type":34},"2025-09-10",{"date":64,"type":22},"2025-10-01",{"date":66,"type":22},"2027-09-15",{"name":68,"class":41},"Applied Biology, Inc.",{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":50,"enrollmentInfo":74,"targetDuration":4,"studyType":23,"phases":76,"briefSummary":78,"conditions":79,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":86,"locationsCount":4},"100573365","phase-3-clinical-study-of-cs-001-as-a-treatment-for-canities-grey-hair-100573365","NCT06745336","Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)",{"count":75,"type":22},240,[77],"PHASE3","Clinical Study to Assess the Safety and Efficacy of CS-001 as a treatment for Canities (Grey Hair)",[29,58],"2024-12-19",{"date":82,"type":34},"2024-12-24",{"date":84,"type":22},"2025-06-15",{"date":66,"type":22},{"name":68,"class":41}]